Precigen, Inc.
PGEN
$3.51
$0.030.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 58.48% | -2.13% | -23.40% | -37.39% | -41.55% |
| Total Other Revenue | 172.00% | 176.00% | 182.35% | 266.67% | 8.70% |
| Total Revenue | 59.20% | -1.12% | -22.76% | -36.95% | -41.38% |
| Cost of Revenue | 7.57% | 27.06% | 5.29% | -11.61% | 60.01% |
| Gross Profit | -4.23% | -29.53% | -7.80% | 9.43% | -80.11% |
| SG&A Expenses | 56.52% | 23.57% | 11.75% | 2.17% | -2.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.76% | -0.63% | 1.89% | 3.66% | 5.56% |
| Operating Income | -12.91% | 0.61% | -3.38% | -6.50% | -9.19% |
| Income Before Tax | -74.40% | 9.36% | -62.74% | -32.86% | -66.31% |
| Income Tax Expenses | 95.88% | 96.50% | -308.33% | -291.48% | -1,627.12% |
| Earnings from Continuing Operations | -76.88% | 8.04% | -61.65% | -31.63% | -64.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.88% | 8.04% | -61.65% | -31.63% | -64.15% |
| EBIT | -12.91% | 0.61% | -3.38% | -6.50% | -9.19% |
| EBITDA | -16.77% | -3.70% | -7.23% | -9.63% | -16.75% |
| EPS Basic | -155.65% | 20.77% | -46.69% | -22.65% | -47.68% |
| Normalized Basic EPS | -116.83% | -15.29% | -29.58% | -2.87% | 0.21% |
| EPS Diluted | -155.65% | 20.77% | -46.69% | -22.65% | -47.68% |
| Normalized Diluted EPS | -116.83% | -15.29% | -29.58% | -2.87% | 0.21% |
| Average Basic Shares Outstanding | 16.00% | 16.05% | 12.13% | 9.78% | 10.73% |
| Average Diluted Shares Outstanding | 16.00% | 16.05% | 12.13% | 9.78% | 10.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |